Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement

Klaus Hackner; Lisa Hütter; Holger Flick; Michael Grohs; Kastriot Kastrati; Hans Kiener; David Lang; Birgit Mosheimer-Feistritzer; Helmut Prosch; Eva Rath; Otmar Schindler; Florentine Moazedi-Fürst

doi:10.1007/s10405-025-00604-0

Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement

Titel in Übersetzung: Screening auf mit rheumatoider Arthritis assoziierte interstitielle Lungenerkrankung – Delphi-basiertes Konsensus-Statement

Klaus Hackner
, Lisa Hütter
, Holger Flick
, Michael Grohs
, Kastriot Kastrati
, Hans Kiener
, David Lang
, Birgit Mosheimer-Feistritzer
, Helmut Prosch
, Eva Rath
, Otmar Schindler
, Florentine Moazedi-Fürst^*

^*Korrespondierende:r Autor:in für diese Arbeit

Klinische Abteilung für Pneumologie (UK Krems)

Publikation: Beitrag in Fachzeitschrift (peer-reviewed) › Artikel in Fachzeitschrift

Abstract

OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.

METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.

RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.

Titel in Übersetzung	Screening auf mit rheumatoider Arthritis assoziierte interstitielle Lungenerkrankung – Delphi-basiertes Konsensus-Statement
Originalsprache	Englisch
Seiten (von - bis)	87-92
Seitenumfang	6
Fachzeitschrift	Zeitschrift fur Pneumologie
Jahrgang	22
Ausgabenummer	2
DOIs	https://doi.org/10.1007/s10405-025-00604-0
Publikationsstatus	Veröffentlicht - März 2025

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1007/s10405-025-00604-0

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Hackner, K., Hütter, L., Flick, H., Grohs, M., Kastrati, K., Kiener, H., Lang, D., Mosheimer-Feistritzer, B., Prosch, H., Rath, E., Schindler, O., & Moazedi-Fürst, F. (2025). Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement. Zeitschrift fur Pneumologie, 22(2), 87-92. https://doi.org/10.1007/s10405-025-00604-0

@article{8be3d832b1b1489489d66057b97d070d,

title = "Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement",

abstract = "OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.",

keywords = "Antifibrotic agents, Autoimmune diseases, Fibrosis, Mass screening, Risk factors, Arthritis, Rheumatoid/complications, Lung Diseases, Interstitial/diagnosis, Humans, Risk Factors",

author = "Klaus Hackner and Lisa H{\"u}tter and Holger Flick and Michael Grohs and Kastriot Kastrati and Hans Kiener and David Lang and Birgit Mosheimer-Feistritzer and Helmut Prosch and Eva Rath and Otmar Schindler and Florentine Moazedi-F{\"u}rst",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = mar,

doi = "10.1007/s10405-025-00604-0",

language = "English",

volume = "22",

pages = "87--92",

journal = "Zeitschrift fur Pneumologie",

issn = "1613-5636",

publisher = "Springer Medizin",

number = "2",

}

TY - JOUR

T1 - Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement

AU - Hackner, Klaus

AU - Hütter, Lisa

AU - Flick, Holger

AU - Grohs, Michael

AU - Kastrati, Kastriot

AU - Kiener, Hans

AU - Lang, David

AU - Mosheimer-Feistritzer, Birgit

AU - Prosch, Helmut

AU - Rath, Eva

AU - Schindler, Otmar

AU - Moazedi-Fürst, Florentine

N1 - Publisher Copyright: © The Author(s) 2025.

PY - 2025/3

Y1 - 2025/3

N2 - OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.

AB - OBJECTIVE: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a major driver of premature mortality in patients with rheumatoid arthritis (RA). Detection of RA-ILD is crucial but requires awareness among the treating physicians. To date, however, there is no international recommendation concerning screening for ILD in RA patients.METHODS: After a systematic literature review, the modified Delphi technique in combination with the nominal group technique was used to provide a Delphi consensus statement elaborated by an expert panel of pneumonologists, rheumatologists, and a radiologist. Based on the available evidence, several clusters of questions were defined and discussed until consent was reached.RESULTS: A screening algorithm for ILD in patients with RA based on clinical signs, respiratory symptoms, and risk factors has been developed. Further, the recommendations address diagnostic tools for RA-ILD and the follow-up of RA patients qualifying for ILD screening.

KW - Antifibrotic agents

KW - Autoimmune diseases

KW - Fibrosis

KW - Mass screening

KW - Risk factors

KW - Arthritis, Rheumatoid/complications

KW - Lung Diseases, Interstitial/diagnosis

KW - Humans

KW - Risk Factors

UR - https://www.scopus.com/pages/publications/86000427782

U2 - 10.1007/s10405-025-00604-0

DO - 10.1007/s10405-025-00604-0

M3 - Journal article

SN - 1613-5636

VL - 22

SP - 87

EP - 92

JO - Zeitschrift fur Pneumologie

JF - Zeitschrift fur Pneumologie

IS - 2